VC playing field tilts to established companies, funds

Venture investors moved record sums into biotech and pharma firms last year, according to a quarterly look at venture investing in the U.S.

The gains came despite the Covid-19 pandemic, which squelched investing early last year, especially in early-stage companies, according to the PitchBook NVCA Venture Monitor for the fourth quarter and full year of 2020. The report is produced by PitchBook and the National Venture Capital Association, with support from Silicon Valley Bank and Velocity Global. READ MORE